This study reveals that peripheral neuropathy, defined by a NDS score≥6, in type 2 diabetic patients is significantly associated with height, insulin treatment, retinopathy treated with laser, total cholesterol and, particularly to dp-ucMGP plasma levels. Here, INS is linked to peripheral neuropathy.